# A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy

> **NCT02463877** · PHASE2 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 18 (actual)

## Conditions studied

- Cancer

## Interventions

- **PROCEDURE:** Minimally-Invasive Procedure

## Key facts

- **NCT ID:** NCT02463877
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02463877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02463877, "A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02463877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*